Current Report · Items 9.01 · 8-K/A
CDT Equity Inc.
Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (a) Financial statements of businesses or funds acquired. The audited financial statements of Sarborg as of and for the fiscal years ended December 31, 2025 and 2024, and the Related Report of Independent Auditors, including the accompanying notes, are filed as Exhibit 99.1 to this Current Report on Form 8-K/A and are incorporated herein by reference.…
Filed Aug 21, 2026Accepted Aug 21, 2026, 9:27 AM EDTCIK 1896212Accession 0001493152-26-039588
Company context
CDT Equity is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The Company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel therapeutic treatments.
Current securities
Historical securities (3)
Disclosure sections
Items 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 9.01Item 9.01 - Financial Statements and Exhibits
Item
9.01. Financial Statements and Exhibits.
(a) Financial statements of businesses or funds acquired.
The
audited financial statements of Sarborg as of and for the fiscal years ended December 31, 2025 and 2024, and the Related Report of Independent
Auditors, including the accompanying notes, are filed as Exhibit 99.1 to this Current Report on Form 8-K/A and are incorporated herein
by reference.
The
unaudited interim financial statements of Sarborg for the six-month period ended June 30, 2026, including the accompanying notes, are
filed as Exhibit 99.2 to this Current Report on Form 8-K/A and are incorporated herein by reference.
(b) Pro forma financial information.
The
Company’s unaudited pro forma condensed consolidated financial statements and related notes thereto, giving effect to the Sarborg
investment, are filed as Exhibit 99.3 to this Current Report on Form 8-K/A and are incorporated herein by reference.
The
unaudited pro forma financial information is presented for illustrative purposes only and is not intended to represent or be indicative
of the Company’s consolidated results of operations or financial position that would have been reported had the investment and
related transactions been completed as of the dates presented in the unaudited pro forma financial information. The unaudited pro forma
financial information should not be taken as a representation of the Company’s future consolidated results of operations or financial
condition. The pro forma adjustments in the unaudited pro forma financial information are based on available information and certain
assumptions that management believes are reasonable under the circumstances.
(d) Exhibits.
Exhibit Description
No.
99.1 Audited financial statements of Sarborg Limited as of and for the fiscal years ended December 31, 2025 and 2024 and the related Report of Independent Auditors, including the notes thereto.
99.2 Unaudited financial statements of Sarborg Limited as of and for the six months ended June 30, 2026, including the notes thereto.
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
99.3 Unaudited pro forma condensed consolidated financial statements of CDT Equity Inc.
104 Cover
Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
Filed exhibits (2)
EX-99.1 (by filename) ex99-1.htmEX-99.1
2
ex99-1.htm
EX-99.1
Exhibit 99.1
SARBORG
LIMITED
INDEX
TO FINANCIAL STATEMENTS
Page
Audited
Financial Statements of Sarborg Limited:
Report of Independent Registered Public Accounting Firm 2
Balance Sheets as of December 31, 2025 and 2024 3
Statements of Operations for the year ended December 31, 2025 and for the period of inception October 28, 2024 through December 31, 2024 4
Statements of Changes in Equity for the year ended December 31, 2025 and for the period from inception October 28, 2024 through December 31, 2024 5
Statements of Cash Flows for the year ended December 31, 2025 and for the period from inception October 28, 2024 through December 31, 2024 6
Notes to Financial Statements …
Open exhibit ↗EX-99.2 (by filename) ex99-2.htmEX-99.2
3
ex99-2.htm
EX-99.2
Exhibit
99.2
SARBORG
LIMITED
INDEX
TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Page
Unaudited
Condensed Financial Statements of Sarborg Limited:
Unaudited Condensed Balance Sheets as of June 30, 2026 and December 31, 2025 2
Unaudited Condensed Statements of Operations for the six months ended June 30, 2026 and 2025 3
Unaudited Condensed Statements of Changes in Equity for the six months ended June 30, 2026 and 2025 4
Unaudited Condensed Statements of Cash Flows for the six months ended June 30, 2026 and 2025 5
Notes to Unaudited Condensed Financial Statements 6
1
SARBORG
LIMITED
UNUAUDITED
CONDENSED BALANCE SHEETS
(in
thousands)
June 30, December 31,
2026 2025
────────────────────────────────────────────────────────────────────────────────────────…
Open exhibit ↗